Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,982 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia

NCT01263704

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Haemek Medical Center; Hematology Department Afula, Israel
  • Soroka Medical Center; Hematology Deptartment Beersheba, Israel
  • Rambam Medical Center; Heamatology & Bone Marrow Transplantation Haifa, Israel
  • Bnei-Zion Medical Center; Hematology Dept Haifa, Israel
View Trial Details
Completed

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT00963274

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +23 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

Safety Study of SGN-CD70A in Cancer Patients

NCT02216890

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +28 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Cardinal Bernardin Cancer Center / Loyola University Medical Center Maywood, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 17 locations
View Trial Details
Completed

Vorinostat in Children

NCT01422499

Conditions
Children With Relapsed Solid Tumor, Lymphoma or Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Clinic for Pediatric Oncology, Hematology, Immunology and Clinical Cooperation Unit Pediatric Oncology Heidelberg, Baden-Wurttemberg, Germany
  • Childrens's Hospital, Pediatric Oncology and Hematology Augsburg, Germany
  • Prof. Hess Childrens's Hospital, Pediatric Oncology and Hematology Bremen, Germany
  • University Children's Hospital, Pediatric Oncology and Hematology Cologne, Germany
View Trial Details
Completed

Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma

NCT01729806

Conditions
CD20 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Completed

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

NCT01567709

Conditions
Adult B Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Anaplastic Large Cell Lymphoma, +84 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States
View Trial Details
Completed

Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)

NCT01030536

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Indianapolis, Indiana, United States
  • Research Site Bethesda, Maryland, United States
  • Research Site Las Vegas, Nevada, United States
View Trial Details

Related conditions